Long-term follow-up of patients with choroidal neovascularization due to angioid streaks

Maria Guadalupe Martinez-Serrano,1 Abelardo Rodriguez-Reyes,2 Jose Luis Guerrero-Naranjo,1,3 Guillermo Salcedo-Villanueva,1 Jans Fromow-Guerra,1,3 Gerardo García-Aguirre,1,3 Virgilio Morales-Canton,1 Raul Velez-Montoya1,3 1Retina Department, 2Pathology Department, Asociación p...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Martinez-Serrano MG, Rodriguez-Reyes A, Guerrero-Naranjo JL, Salcedo-Villanueva G, Fromow-Guerra J, García-Aguirre G, Morales-Canton V, Velez-Montoya R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Angioid Streaks Choroidal neovascularization long term antiangiogenic bevacizumab ranibizumab outcome. Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/ebcc15f0be5745c6933c51ac7f45d3ec
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ebcc15f0be5745c6933c51ac7f45d3ec
record_format	dspace
spelling	oai:doaj.org-article:ebcc15f0be5745c6933c51ac7f45d3ec2021-12-02T06:29:04ZLong-term follow-up of patients with choroidal neovascularization due to angioid streaks1177-5483https://doaj.org/article/ebcc15f0be5745c6933c51ac7f45d3ec2016-12-01T00:00:00Zhttps://www.dovepress.com/long-term-follow-up-of-patients-with-choroidal-neovascularization-due--peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Maria Guadalupe Martinez-Serrano,1 Abelardo Rodriguez-Reyes,2 Jose Luis Guerrero-Naranjo,1,3 Guillermo Salcedo-Villanueva,1 Jans Fromow-Guerra,1,3 Gerardo García-Aguirre,1,3 Virgilio Morales-Canton,1 Raul Velez-Montoya1,3 1Retina Department, 2Pathology Department, Asociación para Evitar la Ceguera en Mexico, Hospital “Dr Luis Sanchez Bulnes” IAP, 3Macula Retina Consultants, Mexico City, Mexico Background: The following case series describes the long-term anatomical and functional outcome of a group of seven patients with choroidal neovascularization (CNV), secondary to angioid streaks (AS), who were treated with antiangiogenic drugs in a pro re nata (PRN) regimen. After the 4-year mark, visual acuity tends to return to pretreatment level. Treatment delays and lack of awareness and self-referral by the patients are believed to be the cause of the PRN regimen failure. Purpose: To assess the long-term outcomes (>4 years) of patients with CNV due to AS treated with a PRN regimen of antiangiogenic. Methods: This was a retrospective, case series, single-center study. We reviewed the electronic medical records from patients with CNV due to AS. From each record, we noted general demographic data and relevant medical history; clinical presentation, changes in best-corrected visual acuity (BCVA) over time, optical coherent tomography parameters, treatment and retreatment details, and systemic associations. Changes in BCVA and central macular thickness were assessed with a Wilcoxon two-sample test, with an alpha value of ≤0.05 for statistical significance. Results: The mean follow-up time was 53.8±26.8 months. BCVA at baseline was: 1.001±0.62 logMAR; at the end of follow-up: 0.996±0.56 logMAR (P=0.9). Central macular thickness at baseline was: 360.85±173.82 µm; at the end of follow-up: 323.85±100.34 µm (P=0.6). Mean number of intravitreal angiogenic drugs: 6±4.16 injections (range 4–15). Mean time between injections was 3.8±2.7 months (range 1.9–5.8 months). Conclusion: Despite initial anatomical and functional improvement, patients at the end of the follow-up had no visual improvement after a pro re nata regimen of antiangiogenic drugs. The amount of retreatments, number of recurrences, and time between intravitreal injections were similar to previous reports with shorter follow-up. Keywords: angioid streaks, choroidal neovascularization, long term, antiangiogenic, bevacizumab, ranibizumab, outcomeMartinez-Serrano MGRodriguez-Reyes AGuerrero-Naranjo JLSalcedo-Villanueva GFromow-Guerra JGarcía-Aguirre GMorales-Canton VVelez-Montoya RDove Medical PressarticleAngioid StreaksChoroidal neovascularizationlong termantiangiogenicbevacizumabranibizumaboutcome.OphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 23-30 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	Angioid Streaks Choroidal neovascularization long term antiangiogenic bevacizumab ranibizumab outcome. Ophthalmology RE1-994
spellingShingle	Angioid Streaks Choroidal neovascularization long term antiangiogenic bevacizumab ranibizumab outcome. Ophthalmology RE1-994 Martinez-Serrano MG Rodriguez-Reyes A Guerrero-Naranjo JL Salcedo-Villanueva G Fromow-Guerra J García-Aguirre G Morales-Canton V Velez-Montoya R Long-term follow-up of patients with choroidal neovascularization due to angioid streaks
description	Maria Guadalupe Martinez-Serrano,1 Abelardo Rodriguez-Reyes,2 Jose Luis Guerrero-Naranjo,1,3 Guillermo Salcedo-Villanueva,1 Jans Fromow-Guerra,1,3 Gerardo García-Aguirre,1,3 Virgilio Morales-Canton,1 Raul Velez-Montoya1,3 1Retina Department, 2Pathology Department, Asociación para Evitar la Ceguera en Mexico, Hospital “Dr Luis Sanchez Bulnes” IAP, 3Macula Retina Consultants, Mexico City, Mexico Background: The following case series describes the long-term anatomical and functional outcome of a group of seven patients with choroidal neovascularization (CNV), secondary to angioid streaks (AS), who were treated with antiangiogenic drugs in a pro re nata (PRN) regimen. After the 4-year mark, visual acuity tends to return to pretreatment level. Treatment delays and lack of awareness and self-referral by the patients are believed to be the cause of the PRN regimen failure. Purpose: To assess the long-term outcomes (>4 years) of patients with CNV due to AS treated with a PRN regimen of antiangiogenic. Methods: This was a retrospective, case series, single-center study. We reviewed the electronic medical records from patients with CNV due to AS. From each record, we noted general demographic data and relevant medical history; clinical presentation, changes in best-corrected visual acuity (BCVA) over time, optical coherent tomography parameters, treatment and retreatment details, and systemic associations. Changes in BCVA and central macular thickness were assessed with a Wilcoxon two-sample test, with an alpha value of ≤0.05 for statistical significance. Results: The mean follow-up time was 53.8±26.8 months. BCVA at baseline was: 1.001±0.62 logMAR; at the end of follow-up: 0.996±0.56 logMAR (P=0.9). Central macular thickness at baseline was: 360.85±173.82 µm; at the end of follow-up: 323.85±100.34 µm (P=0.6). Mean number of intravitreal angiogenic drugs: 6±4.16 injections (range 4–15). Mean time between injections was 3.8±2.7 months (range 1.9–5.8 months). Conclusion: Despite initial anatomical and functional improvement, patients at the end of the follow-up had no visual improvement after a pro re nata regimen of antiangiogenic drugs. The amount of retreatments, number of recurrences, and time between intravitreal injections were similar to previous reports with shorter follow-up. Keywords: angioid streaks, choroidal neovascularization, long term, antiangiogenic, bevacizumab, ranibizumab, outcome
format	article
author	Martinez-Serrano MG Rodriguez-Reyes A Guerrero-Naranjo JL Salcedo-Villanueva G Fromow-Guerra J García-Aguirre G Morales-Canton V Velez-Montoya R
author_facet	Martinez-Serrano MG Rodriguez-Reyes A Guerrero-Naranjo JL Salcedo-Villanueva G Fromow-Guerra J García-Aguirre G Morales-Canton V Velez-Montoya R
author_sort	Martinez-Serrano MG
title	Long-term follow-up of patients with choroidal neovascularization due to angioid streaks
title_short	Long-term follow-up of patients with choroidal neovascularization due to angioid streaks
title_full	Long-term follow-up of patients with choroidal neovascularization due to angioid streaks
title_fullStr	Long-term follow-up of patients with choroidal neovascularization due to angioid streaks
title_full_unstemmed	Long-term follow-up of patients with choroidal neovascularization due to angioid streaks
title_sort	long-term follow-up of patients with choroidal neovascularization due to angioid streaks
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/ebcc15f0be5745c6933c51ac7f45d3ec
work_keys_str_mv	AT martinezserranomg longtermfollowupofpatientswithchoroidalneovascularizationduetoangioidstreaks AT rodriguezreyesa longtermfollowupofpatientswithchoroidalneovascularizationduetoangioidstreaks AT guerreronaranjojl longtermfollowupofpatientswithchoroidalneovascularizationduetoangioidstreaks AT salcedovillanuevag longtermfollowupofpatientswithchoroidalneovascularizationduetoangioidstreaks AT fromowguerraj longtermfollowupofpatientswithchoroidalneovascularizationduetoangioidstreaks AT garciaaguirreg longtermfollowupofpatientswithchoroidalneovascularizationduetoangioidstreaks AT moralescantonv longtermfollowupofpatientswithchoroidalneovascularizationduetoangioidstreaks AT velezmontoyar longtermfollowupofpatientswithchoroidalneovascularizationduetoangioidstreaks
_version_	1718399908591960064

Long-term follow-up of patients with choroidal neovascularization due to angioid streaks

Ejemplares similares